Voyvodic, Peter L.
Conejero, Ismael
Mesmoudi, Khouloud
Renard, Eric
Courtet, Philippe
Cattoni, Diego I.
Bonnet, Jerome
Funding for this research was provided by:
Agence Nationale de la Recherche
European Research Council
Article History
Received: 20 May 2022
Accepted: 27 July 2022
First Online: 12 August 2022
Competing interests
: P.L.V. is a shareholder at Twist Bioscience (NYSE: TWST), which was used to synthesize the murine RNase inhibitor.